We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

101 hedge funds and large institutions have $141M invested in Cytokinetics in 2013 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

886% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 7

273% more call options, than puts

Call options by funds: $4.75M | Put options by funds: $1.27M

159% more funds holding

Funds holding: 39 → 101 (+62)

19% more capital invested

Capital invested by funds: $119M → $141M (+$22.1M)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
101
Holders Change
+62
Holders Change %
+158.97%
% of All Funds
3.27%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
69
Increased
15
Reduced
13
Closed
7
Calls
$4.75M
Puts
$1.27M
Net Calls
+$3.48M
Net Calls Change
-$1.09M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.9M
2
BIT
BlackRock Institutional Trust
California
+$9.49M
3
BFA
BlackRock Fund Advisors
California
+$8.02M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$7.59M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.1M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$20.6M
2
EI
EAM Investors
California
-$2.34M
3
GACM
Green Arrow Capital Management
New York
-$2.15M
4
PAA
Peregrine Asset Advisers
Oregon
-$530K
5
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$482K
Name Holding Trade Value Shares
Change 		Change in
Stake
SGAM
26
Smith Group Asset Management
Texas
$1.07M +$1.51M +141,122 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1M +$1.42M +132,384 New
TCIM
28
TIAA CREF Investment Management
New York
$1M +$66K +6,152 +5%
GAI
29
General American Investors
New York
$996K -$32 -3 -0%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$919K +$318K +29,644 +32%
IGIM
31
I.G. Investment Management
Manitoba, Canada
$868K +$1.23M +114,300 New
WMSA
32
Weiss Multi-Strategy Advisers
New York
$839K -$107K -10,000 -8%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$839K -$37.1K -3,457 -3%
CA
34
Commerzbank Aktiengesellschaft
Germany
$819K +$1.16M +108,134 New
GACM
35
Green Arrow Capital Management
New York
$757K -$2.15M -200,000 -67%
TC
36
TFS Capital
Pennsylvania
$739K +$1.05M +97,656 New
KIA
37
Kopp Investment Advisors
Minnesota
$713K -$142K -13,204 -12%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$694K +$956K +89,150 New
BIM
39
BlackRock Investment Management
Delaware
$590K +$836K +77,970 New
DC
40
Deere & Company
Illinois
$552K +$782K +72,880 New
CS
41
Credit Suisse
Switzerland
$496K +$703K +65,577 New
CC
42
Curian Capital
Colorado
$488K +$393K +36,613 +131%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$487K +$688K +64,181 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$437K +$618K +57,575 New
HVC
45
Healthcare Value Capital
New Jersey
$429K -$107K -10,000 -15%
NI
46
Numeric Investors
Massachusetts
$412K +$583K +54,400 New
BCM
47
Bridgeway Capital Management
Texas
$406K +$575K +53,633 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$362K +$48.3K +4,500 +10%
HCM
49
Highbridge Capital Management
New York
$342K +$328K +30,588 +212%
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$335K -$1.78K -166 -0.4%
1
2
3 4 5

CYTK Hedge Fund Activity: Q3 2013 in Review

101 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2013, worth a combined $141M — up 19% from $119M a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new CYTK positions and 7 closed out — a net gain of 62 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $19.9M. The largest seller was Deerfield Management, exiting entirely with an estimated $20.6M sold.

  • 101 institutional investors held Cytokinetics (CYTK) as of Q3 2013, up from 39 in Q2 2013.
  • Funds reported $141M of Cytokinetics stock for Q3 2013, up 19% quarter-over-quarter.
  • 69 funds opened new Cytokinetics positions in Q3 2013 and 7 closed out, a net change of +62 holders.
  • The largest Cytokinetics buyer in Q3 2013 was Fidelity Investments, an estimated $19.9M added.
  • The largest Cytokinetics seller in Q3 2013 was Deerfield Management, an estimated $20.6M sold.

Based on aggregated 13F filings for Q3 2013.